SQI Diagnostics Abandons Bid to Acquire Scienion, Withdraws IPO | GenomeWeb

This story has been updated to include comments from company officials.

By Justin Petrone

Scienion this week announced the termination of its acquisition agreement with SQI Diagnostics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.